WallStreetZenWallStreetZen

NASDAQ: NOVT
Novanta Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their NOVT stock forecasts and price targets.

Forecast return on equity

Is NOVT forecast to generate an efficient return?
Company
N/A
Industry
1.98%
Market
39.07%

Forecast return on assets

Is NOVT forecast to generate an efficient return on assets?
Company
N/A
Industry
0.8%

NOVT revenue forecast

What is NOVT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$880.2M-0.93%
Avg 2 year Forecast
$897.9M+1.06%
Avg 3 year Forecast
$1.0B+13.16%
NOVT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NOVT earnings growth forecast

How is NOVT forecast to perform vs Scientific & Technical Instruments companies and vs the US market?
Company
54.09%
Industry
25.71%
Market
21.56%
NOVT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NOVT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NOVT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NOVT revenue growth forecast

How is NOVT forecast to perform vs Scientific & Technical Instruments companies and vs the US market?
Company
2.19%
Industry
2.54%
Market
6.64%
NOVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NOVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NOVT vs Scientific & Technical Instrument Stocks

TickerPricePrice TargetUp/downsideConsensus
NOVT$153.89N/AN/A
MKSI$84.06$105.33+25.31%Buy
VNT$34.24$38.00+10.98%Strong Buy
ST$33.36$42.33+26.90%Buy
COHR$41.38$39.27-5.11%Buy
View Top Scientific & Technical Instrument Stocks

Novanta Stock Forecast FAQ

What is NOVT's revenue growth forecast for 2023-2025?

(NASDAQ: NOVT) Novanta's forecast annual revenue growth rate of 2.19% is not forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 2.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.64%.

Novanta's revenue in 2023 is $888,466,000.On average, 1 Wall Street analysts forecast NOVT's revenue for 2023 to be $31,519,571,467, with the lowest NOVT revenue forecast at $31,519,571,467, and the highest NOVT revenue forecast at $31,519,571,467. On average, 1 Wall Street analysts forecast NOVT's revenue for 2024 to be $32,154,489,327, with the lowest NOVT revenue forecast at $32,154,489,327, and the highest NOVT revenue forecast at $32,154,489,327.

In 2025, NOVT is forecast to generate $36,002,671,687 in revenue, with the lowest revenue forecast at $36,002,671,687 and the highest revenue forecast at $36,002,671,687.

If you're new to stock investing, here's how to buy Novanta stock.

What is NOVT's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: NOVT) forecast ROA is N/A, which is lower than the forecast US Scientific & Technical Instruments industry average of 0.8%.

What is NOVT's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: NOVT) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.